CLINICAL_TRIALS
trial_result
· 2021-04-06
Clinical Trial Update: Hydration Based on Thoitaine, Aloe Vera and Calendula, in the Prevention of Hand-Foot Syndrome in Patients Using Capecitabine [Phase 2]
Summary
Phase 2 study evaluating hydration regimens with Thoitaine, Aloe Vera, and Calendula to prevent Hand-Foot Syndrome in patients treated with capecitabine.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Instituto Brasileiro de Controle do Cancer | Conditions: Hand-foot Syndrome | Phase 2 | Status: UNKNOWN